Biotech Stocks Are Lagging, Time to Rebalance Your Healthcare Portfolio? Update-3
Update-3 10/15/21 10/15/21...9/20a Broad rally carries biotech stocks off recent bottom with IBB to $155 to $157.87...XBI up 1.67% to $127.10. But technology shares gave been stronger. Retail sales rise 0.7% despite supply chain issues. Pre-market looks good with futures up. Earnings...
A Pivotal Month for Biotech Stocks After a Sell-Off Week…Update-2
Update-2 10/7/21...Nice broad rally day with temporary relief from the political spat on the debt ceiling. All of our mid-cap focus stocks were up: CRSP CYRX PACB QDEL and VCYT. We need to get confirmation of bottom on small/mid caps in life science stocks with XBI now at $123.91. Quidel...
Biotech Playbook Revisited As Technicals Weaken…Update-3
Update-3 10/1 10:35a ...Merck Oral COVID Drug disrupts markets.MRK up 9% vaccine stocks down. IBB down 3.2% to $156 handle. Update-3 (continued at 10/1 close) Merck oral COVID drug leads rally with all major Indices up, Dow Up 1.43%, S&P 500 up 1.15%, NAZ up 0.82%. A sense of optimism about...
Biotech and Healthcare Portfolio 2021 as of 9/17…Update-3
Update 3...IBB teetering along SEP Support of $170: 9/24..A lot of red today XBI down 2%. Large caps down as well. BNTX down over 5%. Update-2 Another good day for life science stocks. Still expecting a Q4 biotech bounce in small/mid-cap stocks. FED Meeting supports bullish outlook on the...
Look for the Q4 Biotech Bounce in Mid-Small Caps…Update-1
Biotech Bounce in Mid-Small Caps- life science stocks find buyers. Bellwether tickers : ARKG up 3% to $83.93, XBI up 1.44% to $132.88. Update-1 ...Triple witching selling pressure again as expected but a little green at the end of day. DJI down 0.48%, NASDAQ down 0.91%, S&P 500 down 0.91%....